Polymorphisms in drug transporter genes (ABCB1, SLCO1B1 and ABCC2) and hepatitis induced by antituberculosis drugs

被引:23
作者
Kim, Sang-Hoon [2 ]
Kim, Sang-Heon [3 ]
Lee, Jae-Hyung [2 ]
Lee, Byoung-Hoon [2 ]
Kim, Youn-Seup [1 ]
Park, Jae-Seuk [1 ]
Jee, Young-Koo [1 ]
机构
[1] Dankook Univ, Coll Med, Dept Internal Med, Cheonan, South Korea
[2] Eulji Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea
关键词
Drug transporter; Antituberculosis drug; Hepatitis; INDUCED HEPATOTOXICITY; METABOLIZING-ENZYMES; SUSCEPTIBILITY; RISK; MUTATIONS; HAPLOTYPE; GENOTYPE;
D O I
10.1016/j.tube.2011.09.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Unusual drug accumulation is a common mechanism underlying serious drug-induced liver injury. Polymorphisms in three drug transporter genes (ABCB1, SLCO1B1 and ABCC2) may be risk markers for hepatitis induced by the unusual accumulation of anti-tuberculosis drugs (ATDs). We therefore investigated whether polymorphisms and haplotypes of these genes are associated with ATD-induced hepatitis by comparing the frequencies and distributions of single nucleotide polymorphisms and haplotypes of these three drug transporter genes among 67 patients with ATD-induced hepatitis and 159 patients tolerant to ATDs using a multivariate logistic regression analysis. We found that the frequencies of polymorphisms and haplotypes of ABCB1, SLCO1B1 and ABCC2 were similar in patients with ATD-induced hepatitis and ATD-tolerant controls. The present results suggest that these drug transporters do not play important roles in the pathogenesis of ATD-induced hepatitis in Korean patients. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 25 条
[1]
[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603
[2]
BENICHOU C, 1990, J HEPATOL, V11, P272
[3]
MRP2 haplotypes confer differential susceptibility to toxic liver injury [J].
Choi, Ji Ha ;
Ahn, Byung Min ;
Yi, Jihyun ;
Lee, Ji Hyun ;
Lee, Jeong Ho ;
Nam, Soon Woo ;
Chon, Chae Yoon ;
Han, Kwang-Hyub ;
Ahn, Sang Hoon ;
Jang, In-Jin ;
Cho, Joo-Youn ;
Suh, Yousin ;
Cho, Mi-Ook ;
Lee, Jong-Eun ;
Kim, Kyung Hwan ;
Lee, Min Goo .
PHARMACOGENETICS AND GENOMICS, 2007, 17 (06) :403-415
[4]
Genetic susceptibility to diclofenac-induced hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 genotypes [J].
Daly, Ann K. ;
Aithal, Guruprasad P. ;
Leathart, Julian B. S. ;
Swainsbury, Richard A. ;
Dang, Tarana Singh ;
Day, Christopher P. .
GASTROENTEROLOGY, 2007, 132 (01) :272-281
[5]
Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer [J].
Han, Ji-Youn ;
Lim, Hyeong-Seok ;
Yoo, Yeon-Kyeong ;
Shin, Eun Soon ;
Park, Yong Hoon ;
Lee, Sung Young ;
Lee, Jong-Eun ;
Lee, Dea Ho ;
Kim, Heung Tae ;
Lee, Jin Soo .
CANCER, 2007, 110 (01) :138-147
[6]
A haplotype analysis of HER-2 gene polymorphisms:: Association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea [J].
Han, W ;
Kang, D ;
Lee, JE ;
Park, IA ;
Choi, JY ;
Lee, KM ;
Bae, JY ;
Kim, S ;
Shin, ES ;
Lee, JE ;
Shin, HJ ;
Kim, SW ;
Kim, SW ;
Noh, DY .
CLINICAL CANCER RESEARCH, 2005, 11 (13) :4775-4782
[7]
Holden AL, 2002, BIOTECHNIQUES, P22
[8]
Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury [J].
Huang, Yi-Shin .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (01) :1-8
[9]
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis [J].
Huang, YS ;
Chern, HD ;
Su, WJ ;
Wu, JC ;
Lai, SL ;
Yang, SY ;
Chang, FY ;
Lee, SD .
HEPATOLOGY, 2002, 35 (04) :883-889
[10]
Implications of genetic polymorphisms in drug transporters for pharmacotherapy [J].
Kerb, R .
CANCER LETTERS, 2006, 234 (01) :4-33